ArticleFrontiers in medicine2019

Association of Baseline Serum Levels of CXCL5 With the Efficacy of Nivolumab in Advanced Melanoma.

Taku Fujimura et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.